Takanori Inose
Maebashi, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Planned Esophagectomy after Neoadjuvant Hyperthermo-Chemoradiotherapy using Weekly Low-Dose Docetaxel and Hyperthermia for Advanced Esophageal Carcinomas.
Journal: Hepato-gastroenterology
Published: February 24, 2016
Phase II Study of Docetaxel, Nedaplatin, and 5-Fluorouracil Combined Chemotherapy for Advanced Esophageal Cancer.
Journal: Annals of surgical oncology
Published: October 24, 2014
Phase I/II study of docetaxel, cisplatin, and 5-fluorouracil combination chemoradiotherapy in patients with advanced esophageal cancer.
Journal: Cancer chemotherapy and pharmacology
Published: March 22, 2014
L-[3-18F]-α-methyltyrosine accumulation as a definitive chemoradiotherapy response predictor in patients with esophageal cancer.
Journal: Anticancer research
Published: February 11, 2014
Clinical significance of total colonoscopy for screening of colon lesions in patients with esophageal cancer.
Journal: Anticancer research
Published: November 14, 2013
Re-thoracotomy for intrathoracic complications after esophagectomy for esophageal cancer
Journal: Kyobu geka. The Japanese journal of thoracic surgery
Published: August 07, 2013
Expression of receptor tyrosine kinases in esophageal carcinosarcoma.
Journal: Oncology reports
Published: November 14, 2012
Phase I dose-escalation study of docetaxel, nedaplatin, and 5-fluorouracil combination chemotherapy in patients with advanced esophageal cancer.
Journal: Cancer chemotherapy and pharmacology
Published: September 02, 2012
Surgical treatment for nonspecific esophageal motility disorders.
Journal: Surgery today
Published: April 11, 2012
CD47 expression regulated by the miR-133a tumor suppressor is a novel prognostic marker in esophageal squamous cell carcinoma.
Journal: Oncology reports
Published: January 04, 2012
Last Updated: 09/26/2026